RE:RE:RE:Market size?Guessing the Market Size without knowing what indication(s) will be promoted and not having the expensive IMS data by those of us not working directly in the field is like throwing darts really. Abbvie could theory grow the market themselves if they have the only product in its class, a compelling marketing message and resources to do it. Investmentment analysts in this market space are not abundant and likely Abbvie had to do their own market research first, which they did, and they bought the rights to 1067. The Hydroquinone is likely their surrogate benchmark as it seems to be where the money is, and Big Pharma needs big money to make their investments worthwhile.